By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Perosphere Inc. 

24 Old Wagon Road

Bedford  New York  10549  U.S.A.
Phone: n/a Fax: n/a



Company News
Perosphere Inc. Receives FDA Fast Track Designation For Investigational Anticoagulant Reversal Agent PER977 4/2/2015 10:10:04 AM
Perosphere Inc.To Present Investigational Broad-Spectrum Anticoagulant Reversal Agent PER977 Data At American College of Cardiology 64th Annual Scientific Sessions 3/9/2015 10:56:18 AM
Perosphere Inc.’s Anticoagulant Reversal Agent Clinical Trial Results Published In The New England Journal of Medicine 11/6/2014 10:35:02 AM
Perosphere Inc. And Daiichi Sankyo, Inc. (4568.t) Enter Into A Clinical Trial Collaboration Agreement For Phase 3 Studies Of PER977 To Investigate Reversal Of The Anticoagulant Activity Of The Investigational Factor Xa-Inhibitor Edoxaban 10/6/2014 10:28:29 AM
Perosphere Inc. Receives FDA IND Clearance to Initiate Clinical Investigations of the Safety and Efficacy of PER977 to Reverse the Activity of Anticoagulation Therapies Including Factor Xa- and IIa-Inhibitors 5/22/2013 11:07:24 AM
Perosphere Inc. and Daiichi Sankyo, Inc. (4568.t) Enter into a Clinical Trial Agreement to Evaluate the Efficacy and Safety of PER977 to Reverse the Anticoagulant Activity of the Investigational, Oral, Once-Daily Factor Xa Inhibitor Edoxaban 4/25/2013 10:49:34 AM
Perosphere Inc. Launched -- First Close of $1.5 Million Series A Convertible Preferred Stock Offering 12/19/2011 7:31:39 AM